Clinical trials
Hospitalized Patients clinical trials
Below are recruiting hospitalized patients clinical trials, each written for real people, not researchers. We’re tracking 3,592 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05614050Recruiting
Study of outcomes after a heart stent procedure in China
This study follows people with coronary heart disease who get PCI (a procedure to open clogged heart arteries, often with a stent) and looks at their prognosis afterward. It may help researchers understand what affects recovery and outcomes after the procedure.
Wuhan, HubeiAges 18–80 - NCT06794047Recruiting
Vitamin C for IVF in women with low ovarian reserve
This study tests whether taking Vitamin C can improve IVF outcomes for women with low ovarian reserve (DOR). If you are starting your first or second IVF cycle and meet certain health criteria, you may be eligible.
Beijing, Beijing MunicipalityAges 20–45 - NCT06736054RecruitingPhase 1
Testing a new PSMA imaging agent for prostate cancer
This trial tests a new radioactive imaging agent (61Cu-NODAGA-PSMA) to see if it can help find prostate cancer cells. It's for people with prostate cancer that shows up on a PSMA PET/CT scan.
Irvine, CaliforniaAges 18 years+ - NCT06192082Recruiting
Heart risks during painless stomach scope in frail elderly
This study looks at whether older, frail patients have heart problems during a painless stomach scope (gastroscopy). It aims to find safer ways to give sedation for these patients.
Beijing, Beijing MunicipalityAges 65–100 - NCT05616312Recruiting
Study of how patients remember orthopedic injury care
This study looks at how well patients recall details after a bone fracture that required surgery, especially around the time of their injury care and follow-up. It may help improve how orthopedic teams communicate and support patients after trauma.
Cleveland, OhioAges 18–75 - NCT05075512RecruitingPhase 2
Anlotinib with fulvestrant for advanced, HR-positive, HER2-negative breast cancer
This trial studies whether adding anlotinib (a targeted medicine) to fulvestrant (a hormone-blocking injection) can improve outcomes for people with advanced HR-positive, HER2-negative breast cancer. It focuses on safety and effectiveness when cancer has returned or progressed after hormone treatments.
Hangzhou, ZhejiangAges 18 years+ - NCT06375161RecruitingEarly Phase 1
CAR-T cells for relapsed B-cell cancers
This early-phase trial tests a type of immunotherapy called anti-CD19 CAR-T cells. These are specially engineered immune cells that seek out and destroy cancer cells with a marker called CD19 on their surface. It is for people with B-cell cancers (leukemia or lymphoma) that have not responded to or come back after standard treatments.
Shanghai, Shanghai MunicipalityAges 4 months–1.3 years - NCT06975995Recruiting
Postbiotics for elderly dialysis patients
This trial tests whether postbiotics (helpful substances made by good bacteria) can reduce complications in elderly patients on hemodialysis. If you are 65 or older and have been on dialysis for at least 6 months, this study may help improve your treatment.
Beijing, Beijing MunicipalityAges 65 years+ - NCT07527702Recruiting
Comparing suction pressures after lung cancer surgery
This study tests two different suction pressures used on chest tubes after lung cancer surgery to see which helps patients recover better. The goal is to find the safest and most effective way to remove fluid and air from the chest cavity after surgery.
SeoulAges 19 years+ - NCT04788914Recruiting
Test saliva or blood markers to track kidney and leg disease treatment
This study looks at a gene marker (“lncRNA,” a natural molecule in the body) to see how well an oral absorbent, with or without probiotics, is helping people with chronic kidney disease (CKD) who also have blocked leg arteries. It may help doctors better measure treatment impact and tailor care.
Taipei, TaiwanAges 20 years+ - NCT07004647Recruiting
MT027 cell injection for advanced peritoneal tumors
This trial tests an experimental cell therapy, MT027, for people with advanced peritoneal tumors that have stopped responding to standard treatments. The goal is to see if MT027 can shrink tumors when injected directly into the abdomen.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07096479Recruiting
Telpegfilgrastim to prevent low white blood cells in solid tumor patients
This trial tests a once-per-cycle injection (Telpegfilgrastim) to help keep your white blood cell count from dropping dangerously low during chemotherapy. It is for people with solid tumors who are at increased risk for neutropenia (low infection-fighting cells).
Hefei, AnhuiAges 18–70 - NCT07428226Recruiting
Bile acid tests in pregnancy with liver issues
This study looks at bile acid levels in pregnant women who have intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes itching and can affect the baby. It also includes two control groups: healthy pregnant women and healthy non-pregnant women for comparison.
Jena, ThuringiaAges 18–45 - NCT06488352Recruiting
Enhancing care study for heart bypass patients
This trial looks at people who had coronary artery bypass graft (CABG) surgery between 2013 and 2023 to see if better care can improve their recovery. It may help if you had a planned bypass and stayed in the hospital longer than 3 days.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07345962Recruiting
Pregnant patients' hopes and fears about walking epidural
This study asks pregnant women at the CMCO about their hopes and concerns regarding walking epidural (pain relief during labor that allows you to move). It aims to understand what patients think and feel about this option.
StrasbourgAges 18 years+ - NCT07321470Recruiting
Nasogastric tube care after pancreas surgery
This trial compares two ways of managing nasogastric tubes after pancreas and bile duct surgery. One group gets a tube for a while, the other avoids one. It tests if skipping the tube helps recovery.
Taipei, Zhongzheng DistrictAges 20–75 - NCT06141798Recruiting
Dialysis Frequency for Older Adults
This trial compares two versus three times weekly dialysis for people aged 60 or older who are just starting maintenance hemodialysis. It aims to find the best schedule for older adults with end stage kidney disease.
Bucheon-siAges 60 years+ - NCT06924710Recruiting
Adaptive therapy for early stage lung cancer with no MRD detected
This study tests a new approach for people with early-stage non-small cell lung cancer (NSCLC) who have had their tumor completely removed. It uses regular blood tests (MRD monitoring) to watch for any cancer cells left behind, so treatment can be given only if needed.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07374393Enrolling by invitation
Sleep study for people with brain disorders
This study looks at sleep and sleep problems in people with neurological conditions like stroke, Parkinson's, epilepsy, or memory issues. You will do a one-night sleep test (polysomnography) and answer questionnaires to help researchers understand your sleep and daytime function.
Changchun, JilinAges 14–80 - NCT07741006Enrolling by invitationEarly Phase 1
PET imaging study for adults with solid tumors
This study tests a new PET imaging agent called [68Ga]Ga-ELI411 to help see tumors more clearly. It is for adults with solid tumors who are already scheduled for a standard PET scan, and may help doctors better understand and manage their cancer.
Wuhan, HubeiAges 18 years+ - NCT07455214Recruiting
Heart rate variability and breathing trial success in ventilated patients
This study looks at whether heart rate patterns can help predict if a person on a breathing machine is ready to breathe on their own. It may help doctors decide the best time to try removing the breathing tube.
New Taipei CityAges 18–85 - NCT07677319Recruiting
Heart surgery after age 75: a study on recovery
This study looks at how well people aged 75 and older recover after emergency heart surgery. It uses a special test to measure frailty and quality of life for one year after surgery.
Bordeaux, FranceAges 75 years+ - NCT07233811Recruiting
Same-day discharge after robotic hysterectomy
This trial tests if it's safe and beneficial to go home the same day after robotic hysterectomy, compared to staying overnight. It includes women with both benign conditions and endometrial cancer, regardless of weight or uterus size.
StockholmAges 18–75 - NCT07242092RecruitingPhase 4
Pausing methotrexate to boost pneumonia vaccine response
This study tests whether stopping methotrexate for a short time before getting the pneumonia vaccine (PCV20) helps your body build a stronger immune response. It is for people with autoimmune rheumatic diseases like rheumatoid arthritis or lupus whose disease is under control.
São Paulo, São PauloAges 18–100
Hear when a new Hospitalized Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalized patients?
- Yes. Clin2 currently lists 3,592 recruiting hospitalized patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalized patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalized patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.